melloxacan () antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-SMT-206-Ag01	BSA-melloxacan	756
GMP-SMT-206-Ag02	OVA-melloxacan	756
GMP-SMT-206-Ab01	Anti-melloxacan mouse monoclonal antibody (mAb)	1953
GMP-SMT-206-Ab02	Anti-melloxacan mouse monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-SMT-206-Ag01
Product Name	BSA-melloxacan
Target/Biomarker	melloxacan ()
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	melloxacan () antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of Inflammation/autoimmune/inflammatory disease () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-melloxacan () / OVA-melloxacan () is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-206-Ag02
Product Name	OVA-melloxacan
Target/Biomarker	melloxacan ()
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	melloxacan () antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of Inflammation/autoimmune/inflammatory disease () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-melloxacan () / OVA-melloxacan () is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-206-Ab01, GMP-SMT-206-Ab02
Product Name	Anti-melloxacan mouse monoclonal antibody (mAb)
Target/Biomarker	melloxacan ()
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	melloxacan () antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of Inflammation/autoimmune/inflammatory disease () and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-melloxacan () / OVA-melloxacan () is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. Melloxacan, a small molecular compound, emerges as a pivotal entity in the domain of in vitro diagnostics (IVD). Its profound importance lies in its role as a high-specificity and high-sensitivity antigen, making it an indispensable component in various diagnostic assays. Frequently, melloxacan is expertly conjugated to carrier proteins such as Bovine Serum Albumin (BSA) or Ovalbumin (OVA), resulting in the formation of melloxacan-conjugated antigens or immunogens. These conjugates serve as the bedrock upon which a multitude of diagnostic protocols are built, enabling the precise detection and quantification of antibodies or immune responses specifically directed against melloxacan. 2. The imperative to measure melloxacan in IVD stems from a comprehensive array of compelling reasons:    a. Disease Identification and Characterization: Melloxacan-specific antibodies or immune responses often serve as discerning markers for certain medical conditions or exposures to specific agents. Quantitatively assessing melloxacan levels plays an indispensable role in diagnosing related diseases or conditions. For example, the presence of melloxacan-specific antibodies may signify exposure to melloxacan-containing substances, thus aiding in the identification and characterization of associated diseases or conditions.    b. Allergen Profiling: Melloxacan has been implicated in allergies and hypersensitivity reactions in susceptible individuals. Quantifying melloxacan-specific antibodies holds the key to identifying allergic reactions. This insight is invaluable for clinicians and allergists, as it informs clinical decisions and facilitates the development of tailored therapeutic interventions. In-depth allergen profiling involving melloxacan can elucidate the underlying mechanisms of hypersensitivity reactions, contributing to a more profound understanding of allergic diseases.    c. Therapeutic Monitoring: In cases where melloxacan is employed as a medicinal compound or is present in pharmaceutical formulations, the vigilant monitoring of its concentrations in patient specimens is paramount. This practice ensures not only the accuracy of dosing but also the assessment of therapeutic efficacy. Furthermore, monitoring melloxacan levels aids in minimizing potential adverse effects, as it allows for the precise adjustment of treatment regimens to suit individual patient needs.    d. Advancements in Scientific Research: Melloxacan stands as an invaluable asset in the realm of scientific research, particularly within the field of immunology and diagnostics. The quantification of melloxacan enables researchers to explore immune responses with unparalleled precision. This, in turn, contributes to the development of innovative diagnostic assays and therapeutic modalities. By probing the nuances of melloxacan-specific immune reactions, scientists gain valuable insights into the intricacies of the human immune system, potentially paving the way for groundbreaking discoveries and advancements in healthcare. In summary, the quantification of melloxacan in IVD transcends its role as a mere diagnostic tool. It assumes a multifaceted significance, encompassing disease identification, allergen profiling, therapeutic monitoring, and the relentless pursuit of scientific knowledge within the intricate domains of immunology and diagnostics. The nuanced understanding of melloxacan's functions and its quantification within diverse diagnostic contexts fosters a deeper comprehension of the complexities of human health and disease. Furthermore, it underscores the critical role that melloxacan plays in advancing medical research and refining the precision of clinical interventions.

About GDU